1. Home
  2. NUCL vs TTRX Comparison

NUCL vs TTRX Comparison

Compare NUCL & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NUCL

Eagle Nuclear Energy Corp. Common stock

N/A

Current Price

$6.05

Market Cap

308.2M

ML Signal

N/A

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$11.39

Market Cap

298.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NUCL
TTRX
Founded
2023
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
308.2M
298.8M
IPO Year
2026
2025

Fundamental Metrics

Financial Performance
Metric
NUCL
TTRX
Price
$6.05
$11.39
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $25.00
AVG Volume (30 Days)
★ 213.9K
131.9K
Earning Date
10-20-2026
11-25-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$900.00
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.63
$2.57
52 Week High
$14.22
$16.45

Technical Indicators

Market Signals
Indicator
NUCL
TTRX
Relative Strength Index (RSI) 37.90 43.50
Support Level $5.75 $9.02
Resistance Level $6.45 $14.39
Average True Range (ATR) 0.31 1.44
MACD 0.01 -0.42
Stochastic Oscillator 27.50 1.44

Price Performance

Historical Comparison
NUCL
TTRX

About NUCL Eagle Nuclear Energy Corp. Common stock

Eagle Nuclear Energy Corp is a next-generation nuclear energy company that seeks to combine domestic uranium exploration and development with proprietary small modular reactor (SMR) technology. It holds the rights to the mineable, measured and indicated uranium deposit in the United States, referred to as the Aurora Uranium Project, located in southeastern Oregon. The Aurora Uranium Project includes the Aurora deposit, with an estimated 37.73 million pounds of near-surface uranium and the adjacent Cordex Zone Eagle's SMR technology. Eagle's mission is to supply uranium to the growing nuclear energy industry and play a role in the global transition to clean, reliable, and affordable energy.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: